Posizolid

Posizolid is an oxazolidinone antibiotic under investigation by AstraZeneca for the treatment of bacterial infections. At a concentration of 2 mg/L it inhibited 98% of all Gram-positive bacteria tested in vitro.[1]

Posizolid
Clinical data
Other namesAZD2563
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H21F2N3O7
Molar mass465.410 g·mol−1
3D model (JSmol)
 NY (what is this?)  (verify)

References

  1. Wookey A, Turner PJ, Greenhalgh JM, Eastwood M, Clarke J, Sefton C (March 2004). "AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro". Clinical Microbiology and Infection. 10 (3): 247–54. doi:10.1111/j.1198-743X.2004.00770.x. PMID 15008947.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.